BATS BZX Real-Time Price
As of 1:25pm ET
| -0.145 / -0.88%|
The 6 analysts offering 12-month price forecasts for Theravance Inc have a median target of 17.00, with a high estimate of 47.00 and a low estimate of 7.00. The median estimate represents a +4.23% increase from the last price of 16.31.
The current consensus among 7 polled investment analysts is to Hold stock in Theravance Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.